Most patients were able to read several additional
lines on an eye chart after the treatment, and some regained the ability to thread a needle, use a computer or ride a bike.
People could read at least two additional lines
on an eye chart with the treated eye, or letters that were at least one - third smaller than they could read before the study treatment.
If the earnings materialize as forecast, General Mills Inc's True Worth ™ valuation would be $ 53.95 at the end of 2017 (brown
circle on EYE Chart), which would be a 8.8 % annual rate of return from the current price (yellow highlighting).
A person with 20/20 vision can see what the average individual can
see on an eye chart when he is standing 20 feet away.
The patients were followed for more than three years, and half of them were able to read three more
lines on the eye chart, which translated to critical improvements in their daily lives as well.
Those with mild vision loss (20/32 to 20/40) at baseline in all three treatment groups gained on average almost two lines
on an eye chart.
In the University of Pennsylvania trial, led by Jean Bennett, all three patients did better reading lines
on an eye chart.
In a recent clinical trial on patients aged 75 and older, 90 percent of the 219 participants were able to read two lines or more
on an eye chart, and 75 percent could read large - print books.
He explained that visual acuity is a key component in the standard eye - glasses prescription test, where patients «specifically identify the letters
on the eye chart.»